HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 148 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,286,616 | -8.6% | 39,262 | -1.8% | 0.00% | 0.0% |
| Q2 2023 | $1,407,002 | +40.9% | 39,983 | +30.7% | 0.00% | +100.0% |
| Q1 2023 | $998,861 | -41.6% | 30,593 | -1.5% | 0.00% | -66.7% |
| Q4 2022 | $1,711,351 | +25.4% | 31,059 | +0.8% | 0.00% | +50.0% |
| Q3 2022 | $1,365,000 | -10.1% | 30,809 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $1,519,000 | +26.1% | 31,147 | +25.8% | 0.00% | 0.0% |
| Q1 2022 | $1,205,000 | +4.6% | 24,763 | -8.4% | 0.00% | +100.0% |
| Q4 2021 | $1,152,000 | +15.2% | 27,027 | +3.6% | 0.00% | 0.0% |
| Q3 2021 | $1,000,000 | +15.1% | 26,080 | -15.3% | 0.00% | 0.0% |
| Q2 2021 | $869,000 | +180.3% | 30,786 | +227.8% | 0.00% | – |
| Q1 2021 | $310,000 | -8.8% | 9,393 | 0.0% | 0.00% | – |
| Q4 2020 | $340,000 | – | 9,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |